Company Profile

NeuroLight (AKA: Neuroenhancement Lab, Inc)
Profile last edited on: 7/19/24      CAGE: 85RA5      UEI: QMKAADETCSK5

Business Identifier: Optimizing human brain through transplanting mental state.
Year Founded
----
First Award
2022
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

75 Montebello Road Suite 104
Suffern, NY 10901
   (914) 584-6900
   N/A
   www.neuroenhancementlab.com
Location: Single
Congr. District: 17
County: Rockland

Public Profile

In the Fall 2022 it was announced that Neuroenhancement Lab, Inc.-- a neuromodulation company developing technology for transplanting mental states from one person to another - had been renamed/rebranded as NeuroLight. The intent is that the new name, NeuroLight better reflects the shift of the firm -- from using transcranial electric stimulation of the brain -- tinstead to address using light as the primary modality for neurostimulation, brain entrainment, and photo-biomodulation. Suggested as the first company to develop technology for transplanting mental states™ from one person to another, a pilot study done in collaboration with the Neuromodulation Lab at the City College of New York (CCNY/CUNY), used proprietary transcranial electric stimulation (TES) to induce sleep in volunteer subjects with promising results. Subsequent research identified light and sound as ideal stimuli for brain entrainment. This emphasis on light prompted the rebranding. “Further research led us to identify light and sound as ideal stimuli for brain entrainment,” said NeuroLight Founder and President Alexander Poltorak. “This emphasis on light is taking us in new directions and prompted our rebranding and new name.” "Further research led us to identify light and sound as ideal stimuli for brain entrainment," said NeuroLight Founder and President Alexander Poltorak. "This emphasis on light is taking us in new directions and prompted our rebranding and new name." The human brain is naturally entrained by sunlight light, which stimulates photosensitive cells in the retina, signaling the brain to synchronize the endogenous circadian rhythms to local time and day/night cycles. Rhythmic music causes us to instinctively clap hands, tap our feet, or move our bodies in sync with the beat. NeuroLight aims to harness the science of transplanting brain states to help users achieve their desired brain states. For example, the technology may help improve the quality of sleep by recording brain states associated with various stages of sleep in healthy sleepers and then reproducing those states in the brains of people who struggle to achieve quality sleep through neuromodulation using light (photobiomodulation) and sound. "The company's proprietary technology could help people achieve not only better sleep but also higher concentration and performance," Poltorak said. Besides the new name, NeuroLight, this rebranding effort includes a new logo and website—http://www.NeuroLight.co. About NeuroLight, Inc. NeuroLight, Inc. is a neuromodulation R&D company developing pioneering technology for transplanting mental states™ from one person to another (or the same person at a different time). Mental states are represented in the brain by their neural correlates—brainwaves. Transplanting a mental state from a donor to a recipient entails recording brainwaves of the donor while in a desired mental state and then stimulating the brain of the recipient with a waveform extracted from the donor's brainwaves to induce the desired mental state. Besides photobiomodulation using light, NeuroLight also uses auditory stimulation in the form of binaural beats or isochronic tones. The first application the company is working on is the potential treatment of insomnia by entraining a patient's brain with visual and auditory stimuli modulated with a naturalistic waveform derived from endogenous brainwaves of the sleeping donor. This technology is the subject of numerous patent applications. For more information, visit the company's website at http://www

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
25-49

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 1 NSF $255,851
Project Title: Neuromodulation Device to Promote Healthy Sleeping Cycle

Key People / Management

  Alexander Poltorak -- President and Founder

  Mosheh Poltorak -- Chief Commercialization Officer (CCO)

Company News

There are no news available.